ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE
14 August 2019 - 11:00PM
Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES
CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA:
8IS2) Mr. Trevor Dixon, Chief Executive Officer of
Invictus, is pleased to report that Acreage Pharms Ltd.
(“Acreage”), the Company’s wholly owned subsidiary, has been
awarded an oil sales license by Health Canada. Acreage
continues to build an inventory of oils high in CBD, one to one
ratio THC to CBD and high THC to meet the demand of sales to the
medical and recreational markets.
Mr. Dixon stated, “I am pleased that in accordance with our oil
sales license, Acreage is cleared to begin oil shipments to our
customers beginning on August 20, 2019.”
On Behalf of the Board
Trevor Dixon
Chief Executive Officer
Investor Relations 1-844-800-6086
E-Mail: connect@invictus-md.com
Neither the TSX Venture Exchange nor its Regulation
Services Provider accepts responsibility for the adequacy or
accuracy of this release.
About Invictus
Invictus is a global cannabis company with a focus on the
Canadian cannabis space, offering a selection of products under a
wide range of cannabinoid profiles that fit the demand of the
Company’s medical clients and retail customers. The Company’s
integrated sales approach is defined by five pillars of
distribution including medical, adult-use, international, Licensed
Producer to Licensed Producer and sales to provinces.
To meet growing demand, Invictus is expanding its cultivation
footprint with three cannabis production facilities licensed under
the Cannabis Act, which replaced the Access to Cannabis for Medical
Purposes Regulations in Canada. Invictus’ wholly-owned subsidiary
Acreage Pharms Ltd.’s Phase I and Phase II facilities are in full
production and Acreage has substantially completed its Phase III
cultivation facility. AB Laboratories Inc., a company which is a
50% owned subsidiary of Invictus continues its cultivation facility
expansion. Invictus’ wholly owned subsidiary 0989561 B.C. Ltd. (dba
Canandia Bioceuticals) Delta facility is a licensed producer and
has received its sales license issued by Health Canada under the
Cannabis Act. Another of Invictus’ wholly owned subsidiaries,
2015059 Alberta Ltd. (dba Leaf Wise), continues to connect medical
clients to physicians for medical cannabis and to Invictus’ fully
licensed cannabis producers under the Cannabis Act. Future
Harvest Development Ltd., a company which is a 82.5% owned
subsidiary of Invictus continues to produce high-quality fertilizer
and nutrients which are supplied to licensed cannabis producers.
Invictus is targeting up to 50 percent of production to medical
cannabis. Invictus drives sustainable long-term shareholder value
by continuing to develop Invictus’ Canadian production of medical
and recreational cannabis products. For more information
visit www.invictus-md.com.
Kathy Love
Invictus
kathy@invictus-md.com
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Dec 2024 to Jan 2025
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Invictus MD Strategies Corp (TSX Venture Exchange): 0 recent articles
More News Articles